Russell Oakley is recruiting for a Lead CRA to join a Global Biotechnology company based in the London area. The role is a 12 month fixed term contract with the client and will be covering the haematology and oncology therapy areas. The position is full time and field based but will require the incumbent to be in the office for 3 days a week for the first 3 months, followed by a minimum of 1 day a week.
The company was established in 2012 as a centre of excellence in innovation, with the core purpose of building a world-leading cell therapy industry in the UK. Supported by the Technology Strategy Board, their mission is to drive the growth of the industry by helping cell therapy organisations across the world translate early stage research into commercially viable and investable therapies.
We are ideally looking for candidates who have monitoring experience in relevant haematology and/or oncology studies (i.e.. transplantation, leukaemia, lymphoma etc.) from a Phase I setting ideally, but at least Phase II setting. Other CRA experience in Phase I/II trials in complex indications would be useful experience. Also experience is required as a Lead CRA, with lead responsibilities and activities such as managing CRAs, maintaining monitoring schedule, review of monitoring reports with issue resolution & TMF management.
For more information or to apply for this position, please contact Russell Oakley on 01246 457733 or email email@example.com Alternatively, please click on the link below to apply online now.
CK Clinical is an Equal Opportunities employer and welcomes applications from all who meet our selection criteria.
If you do not hear back from us within 15 working days of your application for this role, it means that on this occasion you have not been shortlisted for the next stage of the recruitment campaign. Entitlement to work in the EEA is essential. Please quote reference CL30220 in all correspondence.